We are live on ! Find out more
MVP

Miller Value Partners Portfolio holdings

AUM $383M
1-Year Est. Return 38.57%
This Fund
S&P 500
This Quarter Est. Return
+7.76%
1 Year Est. Return
+38.57%
3 Year Est. Return
+125.13%
5 Year Est. Return
+96.57%
10 Year Est. Return
+721.33%
AUM
$2.35B
AUM Growth
+$24.4M
Cap. Flow
+$16M
Cap. Flow %
0.68%
Top 10 Hldgs %
41.84%
Holding
126
New
12
Increased
24
Reduced
42
Closed
14

Top Buys

Rank Stock Value
1
LUMN icon
Lumen
LUMN
+$47.2M
2
FLXN
Flexion Therapeutics, Inc.
FLXN
+$36.8M
3
WBD icon
Warner Bros
WBD
+$33.3M
4
SFIX
Stitch Fix
SFIX
+$31.8M
5
FTRPR
Frontier Communications Corporation 11.125% Series A Mandatory Convertible Preferred Stock
FTRPR
+$21M

Top Sells

Rank Stock Value
1
MTG icon
MGIC Investment
MTG
+$33.6M
2
RH icon
RH
RH
+$26.3M
3
GILD icon
Gilead Sciences
GILD
+$26.2M
4
AEO icon
American Eagle Outfitters
AEO
+$14.8M
5
JPM.WS
JPMorgan Chase
JPM.WS
+$10.9M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 26.34%
2 Healthcare 20.07%
3 Financials 16.75%
4 Industrials 11.82%
5 Communication Services 9.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WBD icon
26
Warner Bros
WBD
$63.9B
$38.1M 1.62%
+1,702,800
New +$33.3M
MNK
27
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$36.5M 1.55%
1,618,575
+528,700
+49% +$14.2M
SFIX
28
Stitch Fix
SFIX
$547M
$36M 1.53%
+1,393,930
New +$31.8M
AAPL icon
29
CALL
Apple
AAPL
$4.9T
$36M 1.53%
2,049,200
-456,000
-18% -$19.1M
AGN
30
DELISTED
Allergan plc
AGN
$26M 1.11%
159,125
-2,350
-1% -$422K
P
31
DELISTED
Pandora Media Inc
P
$25.6M 1.09%
5,316,325
+22,550
+0.4% +$135K
ATHN
32
DELISTED
Athenahealth, Inc.
ATHN
$22.6M 0.96%
170,045
-16,940
-9% -$2.16M
TCRT icon
33
Alaunos Therapeutics
TCRT
$4.59M
$21M 0.9%
33,895
+1,506
+5% +$1.08M
GME icon
34
GameStop
GME
$9.82B
$19.7M 0.84%
4,390,640
-680
-0% -$3.17K
GTYHU
35
DELISTED
GTY Technology Holdings, Inc. Units
GTYHU
$19.6M 0.83%
1,900,375
-21,500
-1% -$223K
SPY icon
36
State Street SPDR S&P 500 ETF Trust
SPY
$784B
$13.4M 0.57%
50,290
-485
-1% -$126K
TEVA icon
37
Teva Pharmaceuticals
TEVA
$41.2B
$9.78M 0.42%
+516,112
New +$7.76M
APO icon
38
Apollo Global Management
APO
$69.3B
$9.64M 0.41%
288,000
– –
WD icon
39
Walker & Dunlop
WD
$1.68B
$9.5M 0.4%
+200,000
New +$10.2M
PRMW
40
DELISTED
Primo Water Corporation
PRMW
$9.16M 0.39%
550,000
– –
CHGG icon
41
Chegg
CHGG
$118M
$8.98M 0.38%
550,000
– –
STLA icon
42
Stellantis
STLA
$17B
$8.92M 0.38%
500,000
– –
TBT icon
43
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$300M
$8.45M 0.36%
250,000
– –
CG icon
44
Carlyle Group
CG
$16.3B
$7.67M 0.33%
335,000
– –
CS
45
DELISTED
Credit Suisse Group
CS
$6.76M 0.29%
378,715
-5,504
-1% -$91K
CAA
46
DELISTED
CalAtlantic Group, Inc.
CAA
$5.64M 0.24%
100,000
– –
RITM icon
47
Rithm Capital
RITM
$5.51B
$5.57M 0.24%
311,750
– –
CIM
48
Chimera Investment
CIM
$1.06B
$5.17M 0.22%
93,333
– –
ANF icon
49
Abercrombie & Fitch
ANF
$4.45B
$4.97M 0.21%
285,255
-14,275
-5% -$217K
BBDC icon
50
Barings BDC
BBDC
$865M
$4.91M 0.21%
517,278
+270,000
+109% +$2.96M
1
2
3 4 5

Similar funds

DR
Davis Rea Toronto, Ontario, Canada $384M AUM 11.74% 1-Year Est. Return
RC
RV Capital Schindellegi, Switzerland $383M AUM 21.52% 1-Year Est. Return
DSA
Droms Strauss Advisors St. Louis, Missouri $383M AUM 17.99% 1-Year Est. Return
DFA
Delta Financial Advisors New Orleans, Louisiana $384M AUM 26.86% 1-Year Est. Return
PCM
Pinnbrook Capital Management New York $384M AUM 147.48% 1-Year Est. Return
RSS
Rosenblum Silverman Sutton San Francisco, California $382M AUM 13.82% 1-Year Est. Return
T
TOBAM Paris, France $384M AUM 10.32% 1-Year Est. Return
STP
Science & Technology Partners New York $382M AUM 202.26% 1-Year Est. Return

Miller Value Partners's Q4 2017 Portfolio in Review

As of Q4 2017, Miller Value Partners held 126 positions worth $2.35B, up 1% from $2.33B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Miller Value Partners's Q4 2017 filing shows 12 new, 24 increased, 42 reduced and 14 closed positions. Its largest new stake was Lumen: 2,786,450 shares worth $46.5M. The largest sale was MGIC Investment, an estimated $33.6M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

  • Miller Value Partners's largest Q4 2017 buy was Lumen: 2,786,450 shares worth $46.5M.
  • Miller Value Partners added most to Flexion Therapeutics, Inc. in Q4 2017, an estimated $36.8M increase.
  • Miller Value Partners's biggest Q4 2017 reduction was MGIC Investment, cutting an estimated $33.6M.
  • Miller Value Partners fully exited Gilead Sciences in Q4 2017, selling an estimated $26.2M.
  • Miller Value Partners's ten largest holdings make up 42% of its $2.35B portfolio in Q4 2017.
  • Miller Value Partners opened 12 new positions and closed 14 in Q4 2017.
  • Miller Value Partners's portfolio value rose 1% quarter-over-quarter to $2.35B.

Based on Miller Value Partners's 13F filing for Q4 2017, filed 14 Feb 2018.